ASCO 2026: 92% Tumor Shrinkage and 100% Disease Control in Metastatic Pancreatic Cancer with Vopimetostat + Daraxonrasib

Friends, there are numbers that make you stop and take a deep breath before you see or read them. Take a moment and think about metastatic pancreatic cancer – one…

Continue ReadingASCO 2026: 92% Tumor Shrinkage and 100% Disease Control in Metastatic Pancreatic Cancer with Vopimetostat + Daraxonrasib

Gedatolisib + Palbociclib + Fulvestrant Doubled Progression-Free Survival in Metastatic Breast Cancer – VIKTORIA-1 Results at ASCO 2026

New Update: Gedatolisib in the VIKTORIA-1 Study Presented at ASCO 2026 Viktoria is not a patient, and she is not a woman I know... 😊 This is a new study that…

Continue ReadingGedatolisib + Palbociclib + Fulvestrant Doubled Progression-Free Survival in Metastatic Breast Cancer – VIKTORIA-1 Results at ASCO 2026

Amivantamab (Rybrevant FASPRO) – Major Breakthrough in Recurrent/Metastatic Head and Neck Cancer: Pivotal ASCO 2026 Results

A Major Breakthrough in Metastatic Head and Neck Cancer: Amivantamab (Rybrevant FASPRO) Shows Pivotal Results at ASCO 2026 Yesterday (May 31, 2026), mature and highly significant data from the Phase…

Continue ReadingAmivantamab (Rybrevant FASPRO) – Major Breakthrough in Recurrent/Metastatic Head and Neck Cancer: Pivotal ASCO 2026 Results

How to find innovative treatments for metastatic cancer? A short guide for stage 4 patients

How to find innovative treatments for metastatic cancer? A short guide for stage 4 patients Patients with metastatic cancer often encounter situations where it seems that "there is nothing more…

Continue ReadingHow to find innovative treatments for metastatic cancer? A short guide for stage 4 patients

Meet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer

Meet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer Zongertinib (brand name: Hernexeos) is an innovative oral medication that acts as a selective HER2 receptor inhibitor…

Continue ReadingMeet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer

Breakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy

Breakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy A new international study introduces an innovative therapeutic option for glioblastoma (GBM) patients: a personalized vaccine based on the genetic analysis…

Continue ReadingBreakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy

🧠 New treatment for leptomeningeal metastases – hope for advanced-stage cancer patients

🧠 A new treatment for leptomeningeal metastases offers real hope for advanced-stage cancer patients. A groundbreaking study published in Nature Medicine and presented at ASCO 2025 shows promising clinical results…

Continue Reading🧠 New treatment for leptomeningeal metastases – hope for advanced-stage cancer patients